Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it contrast to its competitors? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, risk, valuation, profitability, analyst recommendations, dividends and earnings.
Analyst Recommendations
This is a breakdown of current ratings for Summit Healthcare Acquisition and its competitors, as reported by MarketBeat.
Get Summit Healthcare Acquisition alerts:| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
| Summit Healthcare Acquisition Competitors | 113 | 592 | 886 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 67.59%. Given Summit Healthcare Acquisition's competitors higher possible upside, analysts clearly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.
Insider and Institutional Ownership
64.3% of shares of all "Holding & other investment offices" companies are owned by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.Valuation and Earnings
This table compares Summit Healthcare Acquisition and its competitors top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.55 |
| Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 25.20 |
Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Volatility and Risk
Summit Healthcare Acquisition has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's competitors have a beta of 0.05, indicating that their average share price is 95% less volatile than the S&P 500.
Profitability
This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
| Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
Summary
Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
Summit Healthcare Acquisition Company Profile
(Get Rating)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.